Literature DB >> 27928153

Rheumatoid arthritis: Sarilumab more effective than adalimumab.

Sarah Onuora.   

Abstract

Entities:  

Year:  2016        PMID： 27928153     DOI： 10.1038/nrrheum.2016.207

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.

Authors:  Gerd R Burmester; Yong Lin; Rahul Patel; Janet van Adelsberg; Erin K Mangan; Neil M H Graham; Hubert van Hoogstraten; Deborah Bauer; Juan Ignacio Vargas; Eun Bong Lee
Journal:  Ann Rheum Dis       Date:  2016-11-17       Impact factor: 19.103
  1 in total
  1 in total

Review 1.  Emerging role of targeting macrophages in rheumatoid arthritis: Focus on polarization, metabolism and apoptosis.

Authors:  Xuezhi Yang; Yan Chang; Wei Wei
Journal:  Cell Prolif       Date:  2020-06-12       Impact factor: 6.831
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.